Massachusettes General Hospital grants Santaris an exclusive license to IP related to the regulation of microRNA-33 (miR-33) for cardiovascular disorders

Massachusetts General Hospital

U.S. / Other

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Santaris Pharma A/S

Denmark / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced